MetLife, Inc. (MET) Stock Rating Lowered by ValuEngine

MetLife, Inc. (NYSE:MET) was downgraded by equities researchers at ValuEngine from a “strong-buy” rating to a “buy” rating in a research report issued on Tuesday.

Other equities analysts have also issued research reports about the company. Wells Fargo & Company reiterated a “buy” rating on shares of MetLife in a research note on Saturday, July 1st. Langen Mcalenn restated a “buy” rating on shares of MetLife in a research note on Wednesday, August 16th. J P Morgan Chase & Co began coverage on MetLife in a research note on Monday, July 24th. They set a “hold” rating and a $78.00 price objective on the stock. Royal Bank Of Canada restated a “buy” rating and set a $62.00 price objective on shares of MetLife in a research note on Wednesday, July 12th. Finally, Keefe, Bruyette & Woods restated a “buy” rating and set a $59.00 price objective on shares of MetLife in a research note on Thursday, August 3rd. One research analyst has rated the stock with a sell rating, nine have given a hold rating and nine have given a buy rating to the company. The stock currently has an average rating of “Hold” and an average price target of $57.38.

MetLife (NYSE:MET) opened at 52.85 on Tuesday. MetLife has a 12 month low of $40.53 and a 12 month high of $53.30. The firm has a 50-day moving average price of $49.66 and a 200 day moving average price of $47.81. The company has a market capitalization of $56.17 billion, a P/E ratio of 621.76 and a beta of 1.47.

MetLife (NYSE:MET) last released its quarterly earnings data on Wednesday, August 2nd. The financial services provider reported $1.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.28 by $0.02. The firm had revenue of $17.39 billion for the quarter, compared to analyst estimates of $17.11 billion. MetLife had a return on equity of 8.51% and a net margin of 0.30%. The business’s revenue for the quarter was up 2.5% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.83 earnings per share. Analysts expect that MetLife will post $4.62 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: “MetLife, Inc. (MET) Stock Rating Lowered by ValuEngine” was first posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this article on another website, it was copied illegally and reposted in violation of United States and international copyright laws. The correct version of this article can be accessed at https://ledgergazette.com/2017/10/12/metlife-inc-met-stock-rating-lowered-by-valuengine.html.

Several hedge funds and other institutional investors have recently made changes to their positions in MET. Farmers National Bank purchased a new position in MetLife in the second quarter valued at approximately $118,000. Westside Investment Management Inc. lifted its stake in MetLife by 583.8% in the first quarter. Westside Investment Management Inc. now owns 2,694 shares of the financial services provider’s stock valued at $140,000 after purchasing an additional 2,300 shares during the last quarter. Parallel Advisors LLC lifted its stake in MetLife by 50.7% in the first quarter. Parallel Advisors LLC now owns 2,748 shares of the financial services provider’s stock valued at $143,000 after purchasing an additional 924 shares during the last quarter. First Mercantile Trust Co. lifted its stake in MetLife by 3.4% in the second quarter. First Mercantile Trust Co. now owns 2,926 shares of the financial services provider’s stock valued at $161,000 after purchasing an additional 97 shares during the last quarter. Finally, Carroll Financial Associates Inc. lifted its stake in MetLife by 5.8% in the second quarter. Carroll Financial Associates Inc. now owns 3,013 shares of the financial services provider

Other equities analysts have also issued research reports about the company. Wells Fargo & Company reiterated a “buy” rating on shares of MetLife in a research note on Saturday, July 1st. Langen Mcalenn restated a “buy” rating on shares of MetLife in a research note on Wednesday, August 16th. J P Morgan Chase & Co began coverage on MetLife in a research note on Monday, July 24th. They set a “hold” rating and a $78.00 price objective on the stock. Royal Bank Of Canada restated a “buy” rating and set a $62.00 price objective on shares of MetLife in a research note on Wednesday, July 12th. Finally, Keefe, Bruyette & Woods restated a “buy” rating and set a $59.00 price objective on shares of MetLife in a research note on Thursday, August 3rd. One research analyst has rated the stock with a sell rating, nine have given a hold rating and nine have given a buy rating to the company. The stock currently has an average rating of “Hold” and an average price target of $57.38.

MetLife (NYSE:MET) opened at 52.85 on Tuesday. MetLife has a 12 month low of $40.53 and a 12 month high of $53.30. The firm has a 50-day moving average price of $49.66 and a 200 day moving average price of $47.81. The company has a market capitalization of $56.17 billion, a P/E ratio of 621.76 and a beta of 1.47.

MetLife (NYSE:MET) last released its quarterly earnings data on Wednesday, August 2nd. The financial services provider reported $1.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.28 by $0.02. The firm had revenue of $17.39 billion for the quarter, compared to analyst estimates of $17.11 billion. MetLife had a return on equity of 8.51% and a net margin of 0.30%. The business’s revenue for the quarter was up 2.5% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.83 earnings per share. Analysts expect that MetLife will post $4.62 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: “MetLife, Inc. (MET) Stock Rating Lowered by ValuEngine” was first posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this article on another website, it was copied illegally and reposted in violation of United States and international copyright laws. The correct version of this article can be accessed at https://ledgergazette.com/2017/10/12/metlife-inc-met-stock-rating-lowered-by-valuengine.html.

Several hedge funds and other institutional investors have recently made changes to their positions in MET. Farmers National Bank purchased a new position in MetLife in the second quarter valued at approximately $118,000. Westside Investment Management Inc. lifted its stake in MetLife by 583.8% in the first quarter. Westside Investment Management Inc. now owns 2,694 shares of the financial services provider’s stock valued at $140,000 after purchasing an additional 2,300 shares during the last quarter. Parallel Advisors LLC lifted its stake in MetLife by 50.7% in the first quarter. Parallel Advisors LLC now owns 2,748 shares of the financial services provider’s stock valued at $143,000 after purchasing an additional 924 shares during the last quarter. First Mercantile Trust Co. lifted its stake in MetLife by 3.4% in the second quarter. First Mercantile Trust Co. now owns 2,926 shares of the financial services provider’s stock valued at $161,000 after purchasing an additional 97 shares during the last quarter. Finally, Carroll Financial Associates Inc. lifted its stake in MetLife by 5.8% in the second quarter. Carroll Financial Associates Inc. now owns 3,013 shares of the financial services provider’s stock valued at $165,000 after purchasing an additional 166 shares during the last quarter. Hedge funds and other institutional investors own 74.25% of the company’s stock.

MetLife Company Profile

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Analyst Recommendations for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Inc. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for MetLife Inc. and related companies with MarketBeat.com’s FREE daily email newsletter.

Leave a Reply